Key Details
Price
$133.89Annual Revenue
$1.60 BAnnual EPS
$2.69Annual ROE
6.17%Beta
0.93Events Calendar
Next earnings date:
Feb 14, 2025Recent quarterly earnings:
Oct 24, 2024Recent annual earnings:
Feb 15, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
PLANO, Texas, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading medical device contract development and manufacturing organization, today notified holders of its 2.125% Convertible Senior Notes due 2028 (the “Notes”) that the Notes are convertible, at the option of the holders (the “Conversion Option”) beginning on January 1, 2025, and ending at the close of business on March 31, 2025. The Notes are convertible into cash, up to the principal amount of the Notes, and in cash, shares of the Company's common stock or a combination thereof, at the Company's election, in respect of the remainder, if any, of the Company's conversion obligation in excess of the aggregate principal amount of the Notes being converted. Any determination regarding the convertibility of the Notes during future periods will be made in accordance with the terms of the Indenture governing the Notes.
ITGR's research and product development activities raise optimism about the stock. Rising demand for its products bodes well for the company.
ITGR shares gain on the back of growth in the Medical segment. However, dependence on third-party suppliers is concerning.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ITGR shares gain on the back of growth in the Medical segment. However, fluctuations in the oil and energy market are concerning.
ITGR's third-quarter results reflect solid Medical sales and margin expansion amid the divestiture of its Electrochem business.
Integer (ITGR) came out with quarterly earnings of $1.43 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.27 per share a year ago.
Although the revenue and EPS for Integer (ITGR) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
FAQ
- What is the primary business of Integer Holdings?
- What is the ticker symbol for Integer Holdings?
- Does Integer Holdings pay dividends?
- What sector is Integer Holdings in?
- What industry is Integer Holdings in?
- What country is Integer Holdings based in?
- When did Integer Holdings go public?
- Is Integer Holdings in the S&P 500?
- Is Integer Holdings in the NASDAQ 100?
- Is Integer Holdings in the Dow Jones?
- When was Integer Holdings's last earnings report?
- When does Integer Holdings report earnings?
- Should I buy Integer Holdings stock now?